Use case library
AI use cases from the last 12 months, China and global, each with its source, stage and a quote from the page.
AI IN LIFE SCIENCE · CHINA FIRST, GLOBAL VIEW
Agents collect and classify AI use cases from public sources every day. Reviewers approve them. You get cited cases, process-level analysis and status reports for pharma and medtech.
WHAT YOU GET
From a single cited case to an industry-level view, everything comes from the same reviewed evidence.
AI use cases from the last 12 months, China and global, each with its source, stage and a quote from the page.
Cases mapped to 18 business domains aligned with J&J terminology, with trends, commonalities, differentiators and a point of view.
Versioned status reports for JJIM, JJMT or both. An agent drafts each week; a reviewer approves each edition.
Accepted cases by domain, rule changes, open consultations and company moves for the week, with sources.
HOW IT WORKS
Agents read approved public sources: regulators, company newsrooms and trade press. They respect robots.txt and keep only short quotes from press.
A classification agent maps each case to the process taxonomy and the business unit, and cites the text it relied on.
A named reviewer accepts, corrects or rejects every draft. Nothing counts until a person approves it.
Analyst and report agents draft per-domain analysis and status reports from approved cases only, for review.
HOW WE KEEP IT HONEST